Diverse functions of endothelial NO synthases system: NO and EDH

Journal of Cardiovascular Pharmacology

Volumn 67, Issue 5, 2016, Pages 361-366

  Shimokawa, Hiroaki ^a   Godo, Shigeo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

endothelium dependent hyperpolarization; endothelium derived relaxing factor; hydrogen peroxide; nitric oxide; nitric oxide synthase

Indexed keywords

CAVEOLIN 1; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED RELAXING FACTOR; GUANYLATE CYCLASE; HYDROGEN PEROXIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; BIOLOGICAL FACTOR; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION FACTOR;

ARTERIOLE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CORONARY ARTERY DILATATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION; HOMEOSTASIS; HUMAN; HYPERPOLARIZATION; HYPERTENSION; MESENTERIC ARTERY; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; METABOLISM; VASCULAR ENDOTHELIUM;

ANIMALS; BIOLOGICAL FACTORS; CAVEOLIN 1; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; HUMANS; HYDROGEN PEROXIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE OXYGEN SPECIES;

EID: 84949595814     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000348     Document Type: Article

References (70)

1. Vanhoutte PM. Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J. 2009;73:595-601.
2. Feletou M, Vanhoutte PM. EDHF: an update. Clin Sci (Lond). 2009;117: 139-155.
3. Feletou M, Kohler R, Vanhoutte PM. Nitric oxide: orchestrator of endothelium-dependent responses. Ann Med. 2012;44:694-716.
4. Vanhoutte PM, Shimokawa H, Tang EH, et al. Endothelial dysfunction and vascular disease. Acta Physiol. 2009;196:193-222.
5. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 1988;93:515-524.
6. Chen G, Suzuki H, Weston AH. Acetylcholine releases endotheliumderived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol. 1988;95:1165-1174.
7. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization: no longer an F-word! J Cardiovasc Pharmacol. 2013;61:91-92.
8. Fisslthaler B, Popp R, Kiss L, et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401:493-497.
9. Campbell WB, Gebremedhin D, Pratt PF, et al. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
10. Griffith TM, Chaytor AT, Edwards DH. The obligatory link: role of gap junctional communication in endothelium-dependent smooth muscle hyperpolarization. Pharmacol Res. 2004;49:551-564.
11. Edwards G, Dora KA, Gardener MJ, et al. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998;396:269-272.
12. Tang G, Yang G, Jiang B, et al. H2S is an endothelium-derived hyperpolarizing factor. Antioxid Redox Signal. 2013;19:1634-1646.
13. Matoba T, Shimokawa H, Nakashima M, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest. 2000; 106:1521-1530.
14. Shimokawa H. 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside. Eur Heart J. 2014;35: 3180-3193.
15. Urakami-Harasawa L, Shimokawa H, Nakashima M, et al. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest. 1997;100:2793-2799.
16. Shimokawa H, Yasutake H, Fujii K, et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol. 1996;28:703-711.
17. Prysyazhna O, Rudyk O, Eaton P. Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat Med. 2012;18:286-290.
18. Nakajima S, Ohashi J, Sawada A, et al. Essential role of bone marrow for microvascular endothelial and metabolic functions in mice. Circ Res. 2012;111:87-96.
19. Yada T, Shimokawa H, Hiramatsu O, et al. Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation. 2003;107:1040-1045.
20. Yada T, Shimokawa H, Hiramatsu O, et al. Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo. J Am Coll Cardiol. 2007;50:1272-1278.
21. Takaki A, Morikawa K, Tsutsui M, et al. Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. J Exp Med. 2008;205:2053-2063.
22. Kojima S, Matsui K, Sakamoto T, et al. Long-term nitrate therapy after acute myocardial infarction does not improve or aggravate prognosis. Circ J. 2007;71:301-307.
23. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842-857.
24. Shimokawa H, Morikawa K. Hydrogen peroxide is an endotheliumderived hyperpolarizing factor in animals and humans. J Mol Cell Cardiol. 2005;39:725-732.
25. Nagao T, Illiano S, Vanhoutte PM. Calmodulin antagonists inhibit endothelium-dependent hyperpolarization in the canine coronary artery. Br J Pharmacol. 1992;107:382-386.
26. Matoba T, Shimokawa H, Kubota H, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun. 2002;290:909-913.
27. Miura H, Bosnjak JJ, Ning G, et al. Role for hydrogen peroxide in flowinduced dilation of human coronary arterioles. Circ Res. 2003;92:e31-40.
28. Matoba T, Shimokawa H, Morikawa K, et al. Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol. 2003;23:1224-1230.
29. Lacza Z, Puskar M, Kis B, et al. Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin. Am J Physiol. 2002; 283:H406-H411.
30. Hatoum OA, Binion DG, Miura H, et al. Role of hydrogen peroxide in ACh-induced dilation of human submucosal intestinal microvessels. Am J Physiol. 2005;288:H48-H54.
31. Chaytor AT, Edwards DH, Bakker LM, et al. Distinct hyperpolarizing and relaxant roles for gap junctions and endothelium-derived H2O2 in NO-independent relaxations of rabbit arteries. Proc Natl Acad Sci U S A. 2003;100:15212-15217.
32. Yada T, Shimokawa H, Hiramatsu O, et al. Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo. Am J Physiol. 2006;291: H1138-H1146.
33. Burgoyne JR, Oka S, Ale-Agha N, et al. Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system. Antioxid Redox Signal. 2013;18:1042-1052.
34. Schroder E, Eaton P. Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations. Curr Opin Pharmacol. 2008;8:153-159.
35. Lassegue B, San Martin A, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res. 2012;110:1364-1390.
36. Morikawa K, Shimokawa H, Matoba T, et al. Pivotal role of Cu,Znsuperoxide dismutase in endothelium-dependent hyperpolarization. J Clin Invest. 2003;112:1871-1879.
37. Takaki A, Morikawa K, Murayama Y, et al. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice. J Cardiovasc Pharmacol. 2008;52:510-517.
38. Larsen BT, Bubolz AH, Mendoza SA, et al. Bradykinin-induced dilation of human coronary arterioles requires NADPH oxidase-derived reactive oxygen species. Arterioscler Thromb Vasc Biol. 2009;29:739-745.
39. Liu Y, Zhao H, Li H, et al. Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res. 2003;93:573-580.
40. Shimokawa H. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pflugers Arch. 2010;459:915-922.
41. Burgoyne JR, Madhani M, Cuello F, et al. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science. 2007;317:1393-1397.
42. Zhang DX, Borbouse L, Gebremedhin D, et al. H2O2-induced dilation in human coronary arterioles: role of protein kinase G dimerization and large-conductance Ca2+-activated K+ channel activation. Circ Res. 2012;110:471-480.
43. Liu Y, Bubolz AH, Mendoza S, et al. H2O2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles. Circ Res. 2011;108:566-573.
44. Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33:829-837.
45. Forstermann U, Li H. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol. 2011;164:213-223.
46. Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric-oxide synthases. J Biol Chem. 2001;276:14533-14536.
47. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
48. Morishita T, Tsutsui M, Shimokawa H, et al. Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Natl Acad Sci U S A. 2005;102:10616-10621.
49. Ohashi J, Sawada A, Nakajima S, et al. Mechanisms for enhanced endothelium-derived hyperpolarizing factor-mediated responses in microvessels in mice. Circ J. 2012;76:1768-1779.
50. Burgoyne JR, Prysyazhna O, Rudyk O, et al. cGMP-dependent activation of protein kinase G precludes disulfide activation: implications for blood pressure control. Hypertension. 2012;60:1301-1308.
51. Enkhjargal B, Godo S, Sawada A, et al. Endothelial AMP-activated protein kinase regulates blood pressure and coronary flow responses through hyperpolarization mechanism in mice. Arterioscler Thromb Vasc Biol. 2014;34:1505-1513.
52. Bauersachs J, Popp R, Hecker M, et al. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 1996;94: 3341-3347.
53. Nishikawa Y, Stepp DW, Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol. 2000;279:H459-H465.
54. Olmos L, Mombouli JV, Illiano S, et al. cGMP mediates the desensitization to bradykinin in isolated canine coronary arteries. Am J Physiol. 1995;268:H865-H870.
55. Mustafa AK, Sikka G, Gazi SK, et al. Hydrogen sulfide as endotheliumderived hyperpolarizing factor sulfhydrates potassium channels. Circ Res. 2011;109:1259-1268.
56. Satoh K, Godo S, Saito H, et al. Dual roles of vascular-derived reactive oxygen species-with a special reference to hydrogen peroxide and cyclophilin A. J Mol Cell Cardiol. 2014;73:50-56.
57. Wong WT, Tian XY, Huang Y. Endothelial dysfunction in diabetes and hypertension: cross talk in ras, BMP4, and ROS-dependent COX-2-derived prostanoids. J Cardiovasc Pharmacol. 2013;61:204-214.
58. Vanhoutte PM. Endothelium-derived free radicals: for worse and for better. J Clin Invest. 2001;107:23-25.
59. Bjelakovic G, Nikolova D, Gluud C. Antioxidant supplements to prevent mortality. JAMA. 2013;310:1178-1179.
60. Shao D, Oka S, Brady CD, et al. Redox modification of cell signaling in the cardiovascular system. J Mol Cell Cardiol. 2012;52:550-558.
61. van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov. 2012;11: 860-872.
62. Trajkovski M, Hausser J, Soutschek J, et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature. 2011;474:649-653.
63. Sun HX, Zeng DY, Li RT, et al. Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension. 2012;60:1407-1414.
64. Kozai D, Ogawa N, Mori Y. Redox regulation of transient receptor potential channels. Antioxid Redox Signal. 2014;21:971-986.
65. Nishida M, Hara Y, Yoshida T, et al. TRP channels: molecular diversity and physiological function. Microcirculation. 2006;13:535-550.
66. Ozkor MA, Murrow JR, Rahman AM, et al. Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease. Circulation. 2011;123:2244-2253.
67. Matsuzawa Y, Sugiyama S, Sugamura K, et al. Digital assessment of endothelial function and ischemic heart disease in women. J Am Coll Cardiol. 2010;55:1688-1696.
68. Kitta Y, Obata JE, Nakamura T, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. 2009;53:323-330.
69. Crea F, Lanza G, Camici P. Mechanisms of coronary microvascular dysfunction. In: Coronary Microvascular Dysfunction. Milan, Italy: Springer; 2014:31-47.
70. Ambrosio G, Del Pinto M, Tritto I, et al. Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the global registry of acute coronary events. Eur Heart J. 2010;31:430-438.